Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats

Microvascular Research

Volumn 53, Issue 2, 1997, Pages 105-112

  Sugimoto, Kazuhiro ^a   Yagihashi, Soroku ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; NITRIC OXIDE SYNTHASE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME INHIBITION; MALE; MICROANGIOPATHY; MICROVASCULATURE; MORPHOMETRICS; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031106418     PISSN: 00262862     EISSN: None     Source Type: Journal    
DOI: 10.1006/mvre.1996.2002     Document Type: Article

References (35)

1. Appenzeller, O., Dhital, K. K., Cowen, T., and Burnstock, G. (1988). The nerves to blood vessels supplying blood to nerves: The innervation of the vasa nervosum. Brain. Res. 304, 383-386.
2. Beggs, J., and Johnson, P. C. (1991). Transperineurial arterioles in human sural nerve. J. Neuropathol. Exp. Neurol. 50, 704-718.
3. Bell, M. A., and Weddell, A. G. M. (1984). A descriptive study of the blood vessels of the sciatic nerve in the rat, man and other mammals. Brain 107, 871-898.
4. Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., and Cerami, A. (1986). Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232, 1629-1632.
5. Cameron, N. E., Cotter, M. A., Dines, K., and Love, A. (1992). Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35, 946-950.
6. Cameron, N. E., Cotter, M. A., Dines, K. C., and Maxfield, E. K. (1993). Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia 36, 516-522.
7. Cameron, N. E., Cotter, M. A., and Robertson, S. (1991). Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats. Diabetes 40, 532-539.
8. Corbett, J. A., Tilton, R. G., Chang, K., Hasan, K. S., Ido, Y., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Williamson, J. R., and McDaniel, M. L. (1992). Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41, 552-556.
9. Dines, K. C., Cotter, M. A., and Cameron, N. E. (1993). Contrasting effects of treatment with ω-3 and ω-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats. Diabetologia 36, 1132-1138.
10. Dyck, P. J., Hansen, S., Karnes, J., O'Brien, P., Yasuda, H., Windebnk, A., and Zimmerman, B. (1985). Capillary number and percentage closed in human dibetic sural nerve. Proc. Natl. Acad. Sci. USA 82, 2513-2517.
11. Edelstein, D., and Brownlee, M. (1992). Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41, 26-29.
12. Gardiner, S. M., Compton, A. M., Bennett, T., Palmer, R. M. J., and Moncada, S. (1990). Control of regional blood flow by endothelium-derived nitric oxide. Hypertension 15, 486-492.
13. Griffiths, M. J. D., Messent, M., MacAllister, R. J., and Evans, T. W. (1993). Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 110, 963-968.
14. Ido, Y., McHowat, J., Chang, K. C., Arrigoni-Martelli, E., Orfalian, Z., Kilo, C., Corr, P. B., and Williamson, J. R. (1994). Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes 43, 1469-1477.
15. Kihara, M., Schmelzer, J. D., Poduslo, J. F., Curran, G. L., Nickander, K. K., and Low, P. A. (1991). Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc. Natl. Acad. Sci. USA 88, 6107-6111.
16. Low, P. A., Lagerlund, T. D., and McManis, P. G. (1989). Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. Int. Rev. Neurobiol. 31, 355-438.
17. Malik, R. A., Newrick, P. G., Sharma, A. K., Jennings, A., Ah-See, A. K., Mayhew, T. M., Jakubowski, J., Boulton, A. J. M., and Ward, J. D. (1989). Microangiopathy in human diabetic neuropathy: Relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 32, 92-102.
18. Monnier, V. M., Kohn, R. R., and Cerami, A. (1984). Accelerated age-related browning of human collagen in diabetes mellitus. Proc. Natl. Acad. Sci. USA 81, 583-587.
19. Poduslo, J. F., and Curran, G. L. (1992). Increased permeability across the blood-nerve barrier of albumin glycated in vitro from patients with diabetic polyneuropathy. Proc. Natl. Acad. Sci. USA 89, 2218-2222.
20. Powell, H. C., Rosoff, J., and Myers, R. R. (1985). Microangiopathy in human diabetic neuropathy. Acta Neuropathol. (Berlin) 68, 295-305.
21. Rechtand, E., Nervonen, A., Sato, S., and Rapoport, S. I. (1986). Distribution of adrenergic innervation of blood vessels in peripheral nerve. Brain Res. 374, 185-189.
22. Ryle, C., and Donaghy, M. (1994). Non-enzymatic glycation of peripheral nerve proteins in experimental diabetes mellitus. In "Proceedings of PNS meeting," St. Paul. [Abstract 157].
23. Sima, A. A. F., Nathaniel, V., Prashar, A., Bril, V., and Greene, D. A. (1991). Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor. Diabetes 40, 1090-1099.
24. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J. Clin. Invest. 94, 853-859.
25. Tilton, R. G., Chang, K., Hasan, K. S., Smith, S. R., Petrash, J. M., Misko, T. P., Moore, W. M., Currie, M. G., Corbett, J. A., McDaniel, M. L., and Williamson, J. R. (1993). Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 42, 221-232.
26. Timperley, W. R., Boulton, A. J. M., Davies-Jones, G. A. B., Jarratt, J. A., and Ward, J. D. (1985). Small vessel disease in progressive diabetic neuropathy associated with good metabolic control. J. Clin. Pathol. 38, 1030-1038.
27. Vlassara, H., Brownlee, M., and Cerami, A. (1981). Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Proc. Natl. Acad. Sci. USA 78, 5190-5192.
28. Vlassara, H., Blownlee, M., and Cerami, A. (1983). Excessive nonenzymatic glycosylation of peripheral and central nervous system myelin components in diabetic rats. Diabetes 32, 670-674.
29. Wadhwani, K. C., and Rapoport, S. I. (1994). Transport properties of vertebrate blood-nerve barrier: Comparison with blood-brain barrier. Prog. Neurobiol. 43, 235-279.
30. Williams, S. K., Howarth, N. L., Devenny, J. J., and Bitensky, M. W. (1982). Structual and functional consequences of increased tubulin glycosylation in diabetes mellitus. Proc. Natl. Acad. Sci. USA 79, 6546-6550.
31. Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengaard, J. R., Enden, M. V. d., Kilo, C., and Tilton, R. G. (1993). Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42, 801-813.
32. Wolff, D. J., and Lubeskie, A. (1995). Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Arch. Biochem. Biophys. 316, 290-301.
33. Yagihashi, S., Kamijo, M., Baba, M., Yagihashi, N., and Nagai, K. (1992). Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes 41, 47-52.
34. Yasuda, H., and Dyck, P. J. (1987). Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 37, 20-28.
35. Yasuda, H., Sonobe, M., Yamashita, M., Terada, M., Hatanaka, I., Huitian, Z., and Shigeta, Y. (1989). Effect of prostaglandin E1 analogue TFC612 on diabetic neuropathy in streptozocin-induced diabetic rats. Comparison with aldose reductase inhibitor ONO2235. Diabetes 38, 832-838.